Patent · US Active

GSK-3 inhibitors

US9718804B2 · kind B2 · utility

4Cited by

3References

6Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Guanglin Luo · Newtown, US
Ling Chen · Shanghai, CN
Gene M. Dubowchik · Middlefield, US
Swanee E. Jacutin-Porte · Madison, US
Vivekananda M. Vrudhula · Killingworth, US
Senliang Pan · Woodbridge, US
Prasanna Sivaprakasam · Lawrenceville, US
John E. Macor · Guilford, US

Key dates

Filing date	Nov 3, 2014
Grant date	Aug 1, 2017
Priority date	—
Expiry date	Nov 3, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds to treat disorders associated with GSK-3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.